Abstract
Atrial natriuretic peptide (ANP), a recently discovered cardiac hormone, is an important regulator of body fluid homeostasis. Twenty patients with established chronic renal failure and on maintenance haemodialysis were studied before and after dialysis with capillary dialysers. ANP was determined by RIA after extraction. Mean (±SD) pre-dialysis ANP concentration was 146±51 pg/ml and decreased significantly during dialysis to 68±38 pg/ml (p<0.001). Per cent and absolute changes in plasma ANP level correlated significantly with concomitant changes in body weight (r=0.764; p<0.001 and r=0.558; p<0.01, resp.) but not with changes in serum creatinine, blood pressure or serum electrolytes. The obtained results indicate that ANP levels in patients with chronic renal failure are elevated mainly due to fluid overload, and the rapid fall in ANP concentration observed during haemodialysis is caused by the removal of excess fluid from the body.
Similar content being viewed by others
References
Anderson, J. V., Raine, A. E. G., Proudler, A., Bloom, S. R.: Effect of haemodialysis on plasma concentrations of atrial natriuretic peptide in adult patients with chronic renal failure.J. Endocrinol., 110, 193 (1986).
Bates, E. R., Shenker, J., Grekin, R. J.: The relationship between plasma levels of immunoreactive atrial natriuretic hormone and hemodynamic function in man.Circulation, 73, 1155 (1986).
Burnett, J. C. Jr., Opgenorth, T. J., Granger, J. P.: The renal action of atrial natriuretic peptide during control of glomerular filtration.Kidney Int., 30, 16 (1986).
Cody, R. J., Atlas, S. A., Laragh, J. H., Kubo, S. H., Covit, A. B., Ryman, K. S., Shaknovich, A., Pondolfino, K., Clark, M., Camargo, M. J. F., Scarborough, R. M., Lewicki, J. A.: Atrial natriuretic factor in normal subjects and heart failure patients.J. Clin. Invest., 78, 1363 (1986).
Currie, M. G., Geller, D. M., Cole, B. R., Siegel, N. R., Fok, K. F., Adams, S. P., Eubanks, S. R., Galuppi, G. R., Needleman, P.: Purification and sequence analysis of bioactive. atrial peptides (atriopeptins).Science, 223, 67 (1984).
de Bold, A. J., Borenstein, H. B., veress, A. T., Sonnenberg, H.: A rapid and potent natriuretic response to intravenous injection of atrial myocardial extracts in rats.Life Sci., 28, 89 (1981).
Flynn, T. D., de Bold, M. L., de Bold, A. J.: The amino acid sequence of atrial peptide with potent diuretic and natriuretic properties.Biochem. Biophys. Res. Commun., 117, 859 (1983).
Garcia, R., Gauquelin, G., cantin, M., Schiffrin, E. L.: Renal glomerular atrial natriuretic factor receptors in one-kidney, one-clip rats.Hypertension, 11, 185 (1988).
Gutkowska, J., Kuchel, O., Rácz, K., Buu, N. T., Cantin, M., Genest, J.: Increased plasma immunoreactive atrial natriuretic factor concentrations in salt sensitive Dahl rats.Biochem. Biophys. Res. Commun., 136, 411 (1986).
Hasegawa, K., Matsushita, Y., Inoue, T., Morii, H., Ishibashi, M., Yamaji, T.: Plasma levels of atrial natriuretic peptide in patients with chronic renal failure.J. Clin. Endocrinol. Metab., 63, 819 (1986).
Hodsman, G. P., Jackson, B., Debrevi, L. M., Ogawa, K., Johnston, C. I.: Atrial natriuretic factor in chronic renal failure: studies in man and the rat.Clin. Exp. Pharmacol. Physiol., 14, 247 (1987).
Kangawa, K., Matsuo, H.: Purification and complete amino acid sequence of α-human atrial natriuretic polypeptide.Biochem. Biophys. Res. Commun., 118, 131 (1984).
Koepke, J. P., DiBona, G. F.: Blunted natriuresis to atrial natriuretic peptide in chronic sodium-retaining disorders.Am. J. Physiol., 252, F865 (1987).
Kojima, Sh., Inoue, I., Hirata, Y., Kimura, G., Saito, F., Kawano, Y., Satani, M., Ito, K., Omae, T.: Plasma concentrations of immunoreactive atrial natriuretic polypeptide in patients on hemodialysis.Nephron, 46, 45 (1987).
Lang, R. E., Thölken, H., Ganten, D., Luft, F. C., Ruskoaho, H., Unger, Th.: Atrial natriuretic factor—a circulating hormone stimulated by volume loading.Nature, 314, 264 (1985).
Larochelle, P., Cusson, J. R., Gutkowska, J., Schiffrin, E. L., Hamet, P., Kuchel, O., Genest, J., Cantin, M.: Plasma atrial natriuretic factor concentrations in essential and renovascular hypertension.Br. Med. J., 294, 1249 (1987).
Montorsi, P., Tonolo, G., Polonia, J., Hepburn, D., Richards, A. M.: Correlates of plasma atrial natriuretic factor in health and hypertension.Hypertension, 10, 570 (1987).
Ogawa, K., Smith, A. I., Hodsman, G. P., Jackson, B., Woodcock, E. A., Johnston, C. I.: Plasma atrial natriuretic peptide: concentrations and circulating forms in normal man and patients with chronic renal failure.Clin. Exp. Pharmacol. Physiol., 14, 95 (1987).
Ohashi, M., Fujio, N., Nawata, H., Kato, K.-I., Ibayashi, H., Kangawa, K., Matsuo, H.: High plasma concentrations of human atrial natriuretic polypeptide in aged men.J. Clin. Endocrinol. Metab., 64, 81 (1987).
Ortola, F. V., Ballermann, B. J., Anderson, S., Mendez, R. E., Brenner, B. M.: Elevated plasma atrial natriuretic peptide levels in diabetic rats: potential mediator of hyperfiltration.J. Clin. Invest., 80, 670 (1987).
Rascher, W., Tulassay, T., Lang, R. E.: Atrial natriuretic peptide in plasma of volume overloaded children with chronic renal failure.Lancet, II, 303 (1985).
Ruskoaho, H., Tóth, M., Lang, R. E.: Atrial natriuretic peptide secretion: synergistic effect of phorbol ester and A23187.Biochem. Biophys. Res. Commun., 133, 581 (1985).
Sagnella, G. A., Markandu, N. D., Shore, A. C., MacGregor, G. A.: Effects of changes in dietary sodium intake and saline infusion on immunoreactive atrial natriuretic peptide in human plasma.Lancet, II, 1208 (1985).
Sagnella, G. A., Markandu, N. D., Shore, A. C., MacGregor, G. A.: Raised circulating levels of atrial natriuretic peptides in essential hypertension.Lancet, II, 179 (1986).
Saxenhofer, H., Gnädinger, M. P., Weidmann, P., Shaw, S., Schohn, D., Hess, Ch., Uehlinger, D. E., Jahn, H.: Plasma levels and dialysance of atrial natriuretic peptide in terminal renal failure.Kidney Int., 32, 554 (1987).
Schiffrin, E. L., St-Louis, J., Garcia, R., Thibault, G., Cantin, M., Genest, J.: Vascular and adrenal binding sites for atrial natriuretic factor. Effects of sodium and hypertension.Hypertension, 8 (Suppl. I), 141 (1986).
Shenker, Y., Port, F. K., Swartz, R. D., Gross, M. D., Grekin, R. J.: Atrial natriuretic hormone secretion in patients with renal failure.Life Sci., 41, 1635 (1987).
Smith, S., Anderson, S., Ballermann, B. J., Brenner, B. M.: Role of atrial natriuretic peptide in adaptation of sodium excretion with reduced renal mass.J. Clin. Invest., 77, 1395 (1986).
Solomon, L. R., Atherton, J. C., Bobinski, H., Green, R.: Effect of posture on plasma immunoreactive atrial natriuretic peptide concentration in man.Clin. Sci., 71, 299 (1986).
Sterzel, R. B., Luft, F. C., Lang, R. E., Ganten, D.: Effects of atrial natriuretic factor in rats with renal insufficiency.J. Lab. Clin. Med., 110, 63 (1987).
Thibault, G., Carrier, F., Garcia, R., Gutkowska, J., Seidah, N. G., Chrétien, M., Cantin, M., Genest, J.: The human atrial natriuretic factor (hANF): purification and primary structure.Clin. Invest. Med., 7 (Suppl. 2), 59 (1984).
Tulassay, T., Rascher, W., Ganten, D., Schärer, K., Lang, R. E.: Atrial natriuretic peptide and volume changes in children.Clin. Exp. Hypertens., A8, 695 (1986).
Volpe, M., Odell, G., Kleinert, H. D., Müller, F., Camargo, M. J., Laragh, J. H., Maack, Th., Vaughan, E. D. Jr., Atlas, S. M.: Effect of atrial natriuretic factor on blood pressure, renin, and aldosterone in Goldblatt hypertension.Hypertension, 7 (Suppl. I), 43 (1985).
Wilkins, M. R., Wood, J. A., Adu, D., Lote, C. J., Kendall, M. J., Michael, J.: Change in plasma immunoreactive atrial natriuretic peptide during sequential ultrafiltration and haemodialysis.Clin. Sci., 71, 157 (1986).
Yamaji, T., Ishibashi, M., Sekihara, H., Takaku, F., Nakaoka, H., Fuji, J. Plasma levels of atrial natriuretic peptide in primary aldosteronism and essential hypertension.J. Clin. Endocrinol. Metab., 63, 815 (1986).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
de Châtel, R., Makó, J., Tóth, M. et al. Atrial natriuretic peptide (ANP) in patients with chronic renal failure on maintenance haemodialysis. International Urology and Nephrology 23, 177–183 (1991). https://doi.org/10.1007/BF02549716
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02549716